Alnylam Pharmaceuticals Inc
ALNY
$307.99+3.32 (+1.09%)
Jun 13, 2025, 4:00 PM
Financials
| 52Week High | 310.22 | 52Week Low | 152.30 |
| Beta | 0.21 | Current Ratio Annual | 2.78 |
| Current Ratio Quarterly | 3.04 | Gross Margin TTM | 86.01 |
| Market Cap | 39.96B | Net Profit Margin TTM | -11.49 |
| Operating Margin TTM | -4.91 | Price To Book | 346.14 |
| Price To Free Cash Flow TTM | 256.70 | Price To Sales TTM | 17.02 |
| Quick Ratio Annual | 2.61 | Quick Ratio Quarterly | 2.84 |
| Return On Assets TTM | -6.47 | Return On Equity TTM | -352.96 |
| Return On Investment TTM | -23.06 | Revenue Growth3Y | 38.61 |
| Revenue Growth5Y | 59.21 | Revenue Growth Quarterly Yoy | 20.20 |
| Revenue Growth TTMYoy | 17.21 | Revenue Per Share TTM | 18.11 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 591 | 1 | 2 | 8 | 3 | 1 | 129.39M | $28.18B |
| Mar 31, 2025 | 611 | 94 | 73 | 232 | 193 | 77 | 128.90M | $32.10B |
| Change | 20(3%) | 93(9300%) | 71(3550%) | 224(2800%) | 190(6333%) | 76(7600%) | 496.16K(0%) | $3.92B(14%) |